Summarized & reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 3, 2026
Your Testosterone Is "Normal" — And That's the Problem You got your annual physical. Your doctor checked testosterone. It came back at 380 ng/dL. He said, "You're in normal range." You left the office thinking everything was fine. It's not fine. That number — and the way it was interpreted — is one of the biggest failures in modern men's health. And if you're a 42-year-old executive running on…
This dispatch covers Your Testosterone Is "Normal" — And That's the Problem in the research research category, authored by The Peptide Dispatch Editorial Team. Estimated reading time: 9 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.
You got your annual physical. Your doctor checked testosterone. It came back at 380 ng/dL. He said, "You're in normal range." You left the office thinking everything was fine.
It's not fine.
That number — and the way it was interpreted — is one of the biggest failures in modern men's health. And if you're a 42-year-old executive running on cortisol, caffeine, and five hours of sleep, a testosterone level of 380 is a metabolic crisis hiding behind a lab reference range.
Here's what your doctor didn't tell you — and what you need to understand before another year of declining energy, expanding waistline, and eroding cognitive performance slips by.
Standard lab reference ranges for total testosterone span roughly 264–916 ng/dL. That range was built from population-level data — including 80-year-old men with chronic disease.
When your doctor says "normal," he means you fall somewhere inside that massive window. A 45-year-old executive with a testosterone level of 300 is technically "normal." So is a 25-year-old athlete at 850. The clinical utility of that comparison is zero.
Here's the reality: optimal function for men aged 40–55 generally requires total testosterone between 500–800 ng/dL, with free testosterone in the upper quartile of the reference range. Below 500, most men start reporting symptoms — even if they can't articulate what's wrong.
The symptoms don't arrive with a label. They show up as:
Your doctor won't connect these dots because he's looking at a number inside a range. You need someone who understands what that number means for you.
Even if your total testosterone is adequate, it may not be doing its job. The number your annual physical probably didn't check: free testosterone.
Here's the mechanism. Testosterone circulates in three forms:
A man with total testosterone of 600 ng/dL and elevated SHBG might have less biologically active testosterone than a man at 450 with low SHBG. Total testosterone alone is a blunt instrument.
What drives SHBG up in executives?
If your doctor only ordered total testosterone — and most do — he missed the signal entirely.
A competent testosterone evaluation requires more than one number on a lab slip. Here's the minimum panel:
1. Total Testosterone The headline number, but only useful in context. Drawn before 10 AM (testosterone peaks in the morning and drops 20-30% by afternoon). Two separate measurements are required for any clinical diagnosis per Endocrine Society guidelines.
2. Free Testosterone The bioavailable fraction. This is the number that correlates most directly with symptoms. If your doctor didn't order this, you have an incomplete picture. Period.
3. SHBG (Sex Hormone-Binding Globulin) The binding protein that determines how much of your total testosterone is actually available. High SHBG with adequate total T = functional deficiency.
4. Estradiol (E2) Testosterone converts to estrogen via the aromatase enzyme — particularly in visceral fat tissue. An executive carrying 25+ extra pounds around the midsection is likely aromatizing a meaningful percentage of his testosterone into estradiol. Elevated E2 causes water retention, gynecomastia, mood instability, and further suppresses the hypothalamic-pituitary-gonadal (HPG) axis.
5. LH and FSH These pituitary hormones tell you why testosterone is low. Elevated LH with low testosterone = primary hypogonadism (testicular failure). Low LH with low testosterone = secondary hypogonadism (brain isn't sending the signal). The distinction matters because the treatment approach is fundamentally different.
If you've never had all five of these markers drawn together before 10 AM on two separate occasions, you don't have a testosterone assessment. You have a guess.
Here's the part nobody talks about at the concierge medicine clinic: cortisol and testosterone are inversely related, and the executive lifestyle is a cortisol manufacturing operation.
The hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-gonadal (HPG) axis share regulatory infrastructure. When the HPA axis is chronically activated — which it is when you're managing a P&L, sleeping six hours, eating at your desk, and traveling every other week — the HPG axis gets suppressed.
Research published in 2024 in the European Journal of Endocrinology confirmed what clinicians have observed for years: chronically elevated cortisol directly suppresses GnRH pulsatility, which reduces LH secretion, which reduces testicular testosterone production. It's not a mystery. It's endocrinology.
This means that for most executive men, the root cause of suboptimal testosterone isn't aging. It's the metabolic environment they've built around themselves. And no amount of TRT will fix that if the underlying drivers remain unaddressed.
This is why we talk about a systems approach, not a prescription.
Testosterone replacement therapy is a legitimate clinical intervention when indicated. The TRAVERSE trial (2023, New England Journal of Medicine) — the largest cardiovascular safety trial of TRT ever conducted — demonstrated that testosterone therapy in men with hypogonadism and established cardiovascular risk did not increase the incidence of major adverse cardiovascular events. That was a significant finding that changed the risk calculus.
More recent data from 2025-2026 shows TRT in appropriately selected men over 40 can:
But here's what TRT does not fix:
The executives who get the best outcomes from TRT are the ones who fix the foundation first — or simultaneously. Testosterone replacement layered on top of a broken metabolic environment is like putting premium fuel in a car with a cracked engine block.
For men who want to preserve fertility or whose secondary hypogonadism is driven by reversible causes (stress, obesity, sleep deprivation), clomiphene citrate or enclomiphene represents an alternative approach.
These selective estrogen receptor modulators (SERMs) block estrogen feedback at the hypothalamus, tricking the brain into increasing GnRH, LH, and FSH — which stimulates endogenous testosterone production. Unlike exogenous TRT, this approach maintains (and often improves) spermatogenesis.
Enclomiphene, the trans-isomer of clomiphene, has gained significant clinical traction through 2025-2026 as a cleaner option with fewer side effects than traditional clomiphene. For the right patient — particularly a younger executive in his early 40s with secondary hypogonadism and intact testicular function — this can be the smarter first move.
But it requires proper diagnosis. You can't make this call without the full panel above, including LH and FSH. And you need a clinician who understands the difference between primary and secondary hypogonadism, not one who defaults to a testosterone cream because it's easier.
If you're a man between 40 and 60 reading this, here's the actionable path:
Step 1: Get the right labs drawn correctly. Total testosterone, free testosterone, SHBG, estradiol, LH, FSH — drawn before 10 AM, fasted, on two separate occasions. Add DHEA-S, thyroid panel (TSH, free T3, free T4), fasting insulin, and a metabolic panel. This isn't optional. This is the minimum for a real assessment.
Step 2: Stop accepting "normal range" as a diagnosis. A testosterone level of 350 in a 44-year-old man is not normal. It's common. There's a difference. Common means it's frequently seen in a sick population. Normal means it supports optimal function. Those are not the same thing.
Step 3: Address the foundation before (or alongside) any intervention. Sleep: 7+ hours. Non-negotiable. Resistance training: 3-4 sessions per week. Body composition: if your waist circumference exceeds 40 inches, you are aromatizing testosterone into estrogen faster than any intervention can compensate. Stress management: not a luxury — a clinical requirement.
Step 4: Work with a clinician who treats the system, not the symptom. If your provider's entire testosterone evaluation is a single total T draw and a prescription for 200mg/week of testosterone cypionate, find a different provider. You deserve someone who will assess the full hormonal cascade, identify root causes, and build a protocol that addresses your specific metabolic picture.
Testosterone isn't just a sex hormone. It's a metabolic regulator, a cognitive enhancer, a body composition driver, and a cardiovascular modulator. And for most executive men over 40, it's declining faster than it should — not because of aging alone, but because of the metabolic environment that the modern executive lifestyle creates.
The standard medical system will tell you you're fine until you're clearly not. By then, you've lost years of optimization.
Don't wait for the crisis. Get the data. Understand the data. Act on the data.
Ready to see where you actually stand? The 1836 Wellness Protocol Engine Analysis ($299) takes your existing labs and maps them against 76 biomarkers across 7 functional domains — including a full hormonal cascade analysis. Already know you need comprehensive testing? The Executive Diagnostic Panel ($599) includes 45+ biomarkers with mobile phlebotomy, drawn correctly, interpreted by clinicians who understand the difference between "normal" and optimal. Visit 1836wellness.com to get started.
Educational content — not medical advice. Effects described are drawn from cited research in study subjects.